175 related articles for article (PubMed ID: 27100031)
1. A structural insight into the P1S1 binding mode of diaminoethylphosphonic and phosphinic acids, selective inhibitors of alanine aminopeptidases.
Węglarz-Tomczak E; Berlicki Ł; Pawełczak M; Nocek B; Joachimiak A; Mucha A
Eur J Med Chem; 2016 Jul; 117():187-96. PubMed ID: 27100031
[TBL] [Abstract][Full Text] [Related]
2. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
Grembecka J; Mucha A; Cierpicki T; Kafarski P
J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
[TBL] [Abstract][Full Text] [Related]
3. A synthetic method for diversification of the P1' substituent in phosphinic dipeptides as a tool for exploration of the specificity of the S1' binding pockets of leucine aminopeptidases.
Vassiliou S; Xeilari M; Yiotakis A; Grembecka J; Pawełczak M; Kafarski P; Mucha A
Bioorg Med Chem; 2007 May; 15(9):3187-200. PubMed ID: 17337192
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent and selective inhibitors of human aminopeptidases ERAP1 and ERAP2 by screening libraries of phosphorus-containing amino acid and dipeptide analogues.
Węglarz-Tomczak E; Vassiliou S; Mucha A
Bioorg Med Chem Lett; 2016 Aug; 26(16):4122-6. PubMed ID: 27390066
[TBL] [Abstract][Full Text] [Related]
5. An integrated approach to the ligand binding specificity of Neisseria meningitidis M1 alanine aminopeptidase by fluorogenic substrate profiling, inhibitory studies and molecular modeling.
Węglarz-Tomczak E; Poręba M; Byzia A; Berlicki Ł; Nocek B; Mulligan R; Joachimiak A; Drąg M; Mucha A
Biochimie; 2013 Feb; 95(2):419-28. PubMed ID: 23131591
[TBL] [Abstract][Full Text] [Related]
6. New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13.
Grzywa R; Sokol AM; Sieńczyk M; Radziszewicz M; Kościołek B; Carty MP; Oleksyszyn J
Bioorg Med Chem; 2010 Apr; 18(8):2930-6. PubMed ID: 20347318
[TBL] [Abstract][Full Text] [Related]
7. Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases.
Vassiliou S; Węglarz-Tomczak E; Berlicki Ł; Pawełczak M; Nocek B; Mulligan R; Joachimiak A; Mucha A
J Med Chem; 2014 Oct; 57(19):8140-51. PubMed ID: 25192493
[TBL] [Abstract][Full Text] [Related]
8. Identification of very potent inhibitor of human aminopeptidase N (CD13).
Grzywa R; Oleksyszyn J; Salvesen GS; Drag M
Bioorg Med Chem Lett; 2010 Apr; 20(8):2497-9. PubMed ID: 20307982
[TBL] [Abstract][Full Text] [Related]
9. Individual stereoisomers of phosphinic dipeptide inhibitor of leucine aminopeptidase.
Mucha A; Lämmerhofer M; Lindner W; Pawełczak M; Kafarski P
Bioorg Med Chem Lett; 2008 Mar; 18(5):1550-4. PubMed ID: 18262419
[TBL] [Abstract][Full Text] [Related]
10. Novel hydroxamic acid-related phosphinates: inhibition of neutral aminopeptidase N (APN).
Drag M; Grzywa R; Oleksyszyn J
Bioorg Med Chem Lett; 2007 Mar; 17(6):1516-9. PubMed ID: 17270439
[TBL] [Abstract][Full Text] [Related]
11. Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.
Zhang X; Fang H; Zhu H; Wang X; Zhang L; Li M; Li Q; Yuan Y; Xu W
Bioorg Med Chem; 2010 Aug; 18(16):5981-7. PubMed ID: 20637634
[TBL] [Abstract][Full Text] [Related]
12. First synthesis of alpha-aminoalkyl-(N-substituted)thiocarbamoyl-phosphinates: inhibitors of aminopeptidase N (APN/CD13) with the new zinc-binding group.
Grzywa R; Oleksyszyn J
Bioorg Med Chem Lett; 2008 Jul; 18(13):3734-6. PubMed ID: 18524593
[TBL] [Abstract][Full Text] [Related]
13. Phosphinate, sulfonate, and sulfonamidate dipeptides as potential inhibitors of Escherichia coli aminopeptidase N.
Yang KW; Golich FC; Sigdel TK; Crowder MW
Bioorg Med Chem Lett; 2005 Dec; 15(23):5150-3. PubMed ID: 16168644
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual Screening.
Ruggeri C; Drinkwater N; Sivaraman KK; Bamert RS; McGowan S; Paiardini A
PLoS One; 2015; 10(9):e0138957. PubMed ID: 26406322
[TBL] [Abstract][Full Text] [Related]
15. Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.
Jia M; Yang K; Fang H; Xu Y; Sun S; Su L; Xu W
Bioorg Med Chem; 2011 Sep; 19(17):5190-8. PubMed ID: 21802307
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of phosphonic arginine mimetics as inhibitors of the M1 and M17 aminopeptidases from Plasmodium falciparum.
Kannan Sivaraman K; Paiardini A; Sieńczyk M; Ruggeri C; Oellig CA; Dalton JP; Scammells PJ; Drag M; McGowan S
J Med Chem; 2013 Jun; 56(12):5213-7. PubMed ID: 23713488
[TBL] [Abstract][Full Text] [Related]
17. Efficient synthesis of Fmoc-protected phosphinic pseudodipeptides: Building blocks for the synthesis of matrix metalloproteinase inhibitors.
Bhowmick M; Sappidi RR; Fields GB; Lepore SD
Biopolymers; 2011; 96(1):1-3. PubMed ID: 20225219
[TBL] [Abstract][Full Text] [Related]
18. Amino-benzosuberone: a novel warhead for selective inhibition of human aminopeptidase-N/CD13.
Albrecht S; Al-Lakkis-Wehbe M; Orsini A; Defoin A; Pale P; Salomon E; Tarnus C; Weibel JM
Bioorg Med Chem; 2011 Feb; 19(4):1434-49. PubMed ID: 21292493
[TBL] [Abstract][Full Text] [Related]
19. alpha-Aminoalkylphosphonates as a tool in experimental optimisation of P1 side chain shape of potential inhibitors in S1 pocket of leucine- and neutral aminopeptidases.
Drag M; Grembecka J; Pawełczak M; Kafarski P
Eur J Med Chem; 2005 Aug; 40(8):764-71. PubMed ID: 16122579
[TBL] [Abstract][Full Text] [Related]
20. Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
Ma C; Jin K; Cao J; Zhang L; Li X; Xu W
Bioorg Med Chem; 2013 Apr; 21(7):1621-7. PubMed ID: 23453219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
